Luminol dependent chemiluminescence analysis of human platelets.
Microchemical journal, devoted to the application of microtechniques in all branches of science. 1980; 25:514-523.
Luminol-dependent chemiluminescence analysis of human platelets.
Microchemical Journal. 1980 December; 25(4):514-523. doi: 10.1016/0026-265X(80)90216-7.
Abnormal responses of granulocytes in chronic granulomatous disease.
Biochimica et Biophysica Acta (BBA) - Biomembranes. 1981 June; 645(1):49-53. doi: 10.1016/0005-2736(81)90510-1.
Abnormal responses of granulocytes in chronic granulomatous disease.
Biochim Biophys Acta.
1981 Jul 6;645(1):49-53. doi: 10.1016/0005-2736(81)90510-1. PubMed PMID:
6789879.
A novel method for measuring initial burst chemiluminescence in a liquid scintillation counter using the myeloperoxidase-H2O2-CL reaction.
Microchemical journal, devoted to the application of microtechniques in all branches of science. 1982; 27:221-230.
Multipurpose radiomatic automated flow liquid scintillation counter system for measurement of burst of delayed chemiluminescence reaction: model drug inhibition with luminol-dependent myeloperoxidase.
Microchemical journal, devoted to the application of microtechniques in all branches of science. 1982; 27:276-289.
Antioxidant effect of non-steroidal anti-inflammatory drugs (NSAIDs) against PMN myeloperoxidase inflammatory free radicals measured by luminol-enhanced chemiluminescence (CL).
Federation Proceedings. 1982; 41(5):7477.
Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and [3H]FMLP binding. Effect of sulindac sulfide, indomethacin metabolite, and optical enantiomers (+) and (-) MK830.
Inflammation.
1982 Mar;6(1):113-25. doi: 10.1007/BF00910724. PubMed PMID:
7085041.
Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and [3H]FMLP binding.
Inflammation. 1982 March; 6(1):113-125. doi: 10.1007/BF00910724.
Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.
Agents Actions.
1982 Apr;12(1-2):232-8. doi: 10.1007/BF01965152. PubMed PMID:
6282074.
Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.
Agents and Actions. 1982 April; 12(1-2):232-238. doi: 10.1007/BF01965152.
Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction.
Agents and Actions. 1982 June; 12(3):371-376. doi: 10.1007/BF01965406.
A novel method for measuring initial-burst chemiluminescence in a liquid scintillation counter using the myeloperoxidase-H20Cl− reaction.
Microchemical Journal. 1982 June; 27(2):221-230. doi: 10.1016/0026-265X(82)90112-6.
Multipurpose radiomatic automated flow liquid scintillation counter system for measurement of burst or delayed chemiluminescence reactions: Model-drug inhibition with luminol-dependent myeloperoxidase.
Microchemical Journal. 1982 June; 27(2):276-289. doi: 10.1016/0026-265X(82)90118-7.
Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction.
Agents Actions.
1982 Jul;12(3):371-6. doi: 10.1007/BF01965406. PubMed PMID:
6291348.
Temporal sequence of chemiluminescence and aggregation of human neutrophils and platelets after stimulation by arachidonic acid.
Microchemical journal, devoted to the application of microtechniques in all branches of science. 1983; 28:91-98.
Impairment of leukocyte myeloperoxidase bactericidal mechanisms with ketamine (Ketalar®).
Agents and Actions. 1983 January; 13(1):59-62. doi: 10.1007/BF01994283.
Impairment of leukocyte myeloperoxidase bactericidal mechanisms with ketamine (Ketalar).
Agents Actions.
1983 Feb;13(1):59-62. doi: 10.1007/BF01994283. PubMed PMID:
6305176.
Temporal sequence of chemiluminescence and aggregation of human neutrophils and platelets after stimulation by arachidonic acid.
Microchemical Journal. 1983 March; 28(1):91-98. doi: 10.1016/0026-265X(83)90033-4.
The measurement of chemiluminescence, aggregation and 5-hydroxy-6,8,11,14- eicosatetranenoic acid production of n-formal-methanyl-leucyl- phenylalanin-stimulated human polymorphonuclear leukocytes.
Microchemical journal, devoted to the application of microtechniques in all branches of science. 1985; 31:22-28.
Studies of luminol dependent whole blood chemiluminescence induced by platelet activating factor.
Microchemical Journal. 1985; 31:261-271.
The measurement of chemiluminescence, aggregation, and 5-hydroxy-6,8,11,14-eicosatetraenoic acid production of n-formyl-methioninyl-leucyl-phenylalanine-stimulated human polymorphonuclear leukocytes.
Microchemical Journal. 1985 February; 31(1):22-28. doi: 10.1016/0026-265X(85)90004-9.
Studies of luminol-dependent whole-blood chemiluminescence induced by platelet-activating factor (PAF).
Microchemical Journal. 1985 June; 31(3):261-271. doi: 10.1016/0026-265X(85)90112-2.
Studies of neonatal polymorphonuclear leukocyte function using a novel microanalytic chemiluminescence technique.
Microchemical Journal. 1986 October; 34(2):222-229. doi: 10.1016/0026-265X(86)90037-8.
Studies of neonatal polymorhphonuclear leukocyte function using a novel microanalytic chemiluminescence technique.
Microchemical Journal. 1987; 34:222-229.
Diminished chemiluminescent responses of polymorphonuclear leukocytes in severely and moderately preterm neonates.
J Pediatr.
1987 Dec;111(6 Pt 1):904-6. doi: 10.1016/s0022-3476(87)80216-0. PubMed PMID:
3681560.
Diminished chemiluminescent responses of polymorphonuclear leukocytes in severely and moderately preterm neonates.
The Journal of Pediatrics. 1987 December; 111(6):904-906. doi: 10.1016/S0022-3476(87)80216-0.
Uric acid is a major antioxidant in human nasal airway secretions.
Proceedings of the National Academy of Sciences of the United States of America. 1990; 87(19):7643-7647.
Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo.
Am Rev Respir Dis.
1990 Mar;141(3):706-14. doi: 10.1164/ajrccm/141.3.706. PubMed PMID:
2178531.
Bradykinin and Respiratory Mucous Membranes: Analysis of Bradykinin Binding Site Distribution and Secretory Responses <i>In Vitro</i> and <i>In Vivo</i>.
American Review of Respiratory Disease. 1990 March; 141(3):706-714. doi: 10.1164/ajrccm/141.3.706.
Gastrin-releasing peptide in human nasal mucosa.
J Clin Invest.
1990 Apr;85(4):998-1005. doi: 10.1172/JCI114577. PubMed PMID:
2318984; PubMed Central PMCID:
PMC296528.
Gastrin-releasing peptide in human nasal mucosa.
Journal of Clinical Investigation. 1990-4-; 85(4):998-1005. doi: 10.1172/JCI114577.
Uric acid is a major antioxidant in human nasal airway secretions.
Proc Natl Acad Sci U S A.
1990 Oct;87(19):7638-42. doi: 10.1073/pnas.87.19.7638. PubMed PMID:
2217195; PubMed Central PMCID:
PMC54803.
Uric acid is a major antioxidant in human nasal airway secretions.
Proceedings of the National Academy of Sciences. 1990 October; 87(19):7638-7642. doi: 10.1073/pnas.87.19.7638.
Airway hyperresponsiveness in patients with microvascular angina. Evidence for a diffuse disorder of smooth muscle responsiveness.
Circulation.
1990 Dec;82(6):2011-7. doi: 10.1161/01.cir.82.6.2011. PubMed PMID:
2242525.
Airway hyperresponsiveness in patients with microvascular angina. Evidence for a diffuse disorder of smooth muscle responsiveness.
Circulation. 1990 December; 82(6):2011-2017. doi: 10.1161/01.CIR.82.6.2011.
Human nasal glandular secretion of novel antioxidant activity: cholinergic control.
Am Rev Respir Dis.
1991 Mar;143(3):545-52. doi: 10.1164/ajrccm/143.3.545. PubMed PMID:
2001065.
Human Nasal Glandular Secretion of Novel Antioxidant Activity: Cholinergic Control.
American Review of Respiratory Disease. 1991 March; 143(3):545-552. doi: 10.1164/ajrccm/143.3.545.
The effect of IL-4 on human nasal mucosal responses.
J Allergy Clin Immunol.
1992 Nov;90(5):772-81. doi: 10.1016/0091-6749(92)90101-7. PubMed PMID:
1430703.
The effect of IL-4 on human nasal mucosal responses.
Journal of Allergy and Clinical Immunology. 1992 November; 90(5):772-781. doi: 10.1016/0091-6749(92)90101-7.
Nasal secretion of the ozone scavenger uric acid.
Am Rev Respir Dis.
1993 Aug;148(2):455-61. doi: 10.1164/ajrccm/148.2.455. PubMed PMID:
8342911.
Nasal Secretion of the Ozone Scavenger Uric Acid.
American Review of Respiratory Disease. 1993 August; 148(2):455-461. doi: 10.1164/ajrccm/148.2.455.
Hydrogen peroxide effects on rat mast cell function.
American Journal of Physiology - Lung Cellular and Molecular Physiology. 1994; 267(1 11-1).
Hydrogen peroxide effects on rat mast cell function.
Am J Physiol.
1994 Jul;267(1 Pt 1):L85-93. doi: 10.1152/ajplung.1994.267.1.L85. PubMed PMID:
8048546.
Modulation of mast cell functions by in vitro ozone exposure.
American Journal of Physiology - Lung Cellular and Molecular Physiology. 1995; 268(6 12-6).
Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics.
Am J Respir Crit Care Med.
1995 May;151(5):1336-45. doi: 10.1164/ajrccm.151.5.7735583. PubMed PMID:
7735583.
Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics.
American Journal of Respiratory and Critical Care Medicine. 1995 May; 151(5):1336-1345. doi: 10.1164/ajrccm.151.5.7735583.
Modulation of mast cell functions by in vitro ozone exposure.
Am J Physiol.
1995 Jun;268(6 Pt 1):L902-10. doi: 10.1152/ajplung.1995.268.6.L902. PubMed PMID:
7611432.
Nasal lavage cytokines in normal, allergic, and asthmatic school-age children.
Am J Respir Crit Care Med.
1995 Oct;152(4 Pt 1):1290-6. doi: 10.1164/ajrccm.152.4.7551384. PubMed PMID:
7551384.
Nasal lavage cytokines in normal, allergic, and asthmatic school-age children.
American Journal of Respiratory and Critical Care Medicine. 1995 October; 152(4):1290-1296. doi: 10.1164/ajrccm.152.4.7551384.
What would you like to do?